Can combined High-resolution and 3D-Arterial spin labeling MR differentiate moyamoya disease from arteriosclerotic moyamoya syndrome?
Yu Guo, Weiqiang Dou, Xinyu Wang, Xinyi Wang, Huimin Mao, Kunjian Chen
Abstract
Yu Guo, Weiqiang Dou, Xinyu Wang, Xinyi Wang, Huimin Mao, Kunjian Chen
Abstract
This study aimed to investigate whether the combined T1w-CUBE imaging and multiple post-labeling delay 3D pseudo-continuous arterial spin labeling imaging(MP 3D-PcASL)can distinguish moyamoya disease(MMD)from arteriosclerotic moyamoya syndrome(AS-MMS). 26 MMD patients and 25 AS-MMS patients were measured with T1w-CUBE imaging and MP 3D-PcASL. Significantly altered vessel wall in morphology and cerebral perfusion patterns were found on the lesions between AS-MMS and MMD. We thus concluded that the combined T1w-CUBE imaging and MP 3D-PcASL might help distinguish MMD from AS-MMS in clinic.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This study aimed to investigate whether the combined T1w-CUBE imaging and multiple post-labeling delay 3D pseudo-continuous arterial spin labeling imaging(MP 3D-PcASL)can distinguish moyamoya disease(MMD)from arteriosclerotic moyamoya syndrome(AS-MMS). 26 MMD patients and 25 AS-MMS patients were measured with T1w-CUBE imaging and MP 3D-PcASL. Significantly altered vessel wall in morphology and cerebral perfusion patterns were found on the lesions between AS-MMS and MMD. We thus concluded that the combined T1w-CUBE imaging and MP 3D-PcASL might help distinguish MMD from AS-MMS in clinic.
Key concepts: Moyamoya disease, Arterial spin labeling, Medicine, Magnetic resonance imaging, Nuclear medicine, Perfusion, Cube (algebra), Radiology